Top Markets
Coin of the day
Jupiter Wellness, Inc. Jupiter Wellness, Inc.

Jupiter Wellness, Inc.

JUPW
Classement en actions #28087
Jupiter Wellness, Inc. specializes in the development of therapeutic and... Jupiter Wellness, Inc. specializes in the development of therapeutic and wellness products derived from cannabidiol (CBD). Its clinical development portfolio features several innovative candidates, such as CaniDermRX (JW-100), a unique topical blend of CBD and aspartame aimed at addressing eczema, dermatitis, and actinic keratosis. Also in development are JW-101, a prescription solution designed for burn treatment, and JW-200, an over-the-counter lotion or lip balm formulated to alleviate symptoms associated with cold sores. Beyond its clinical efforts, Jupiter Wellness also manufactures, distributes, and markets a range of consumer goods. These include CBD-enriched sunscreens sold under the CaniSun label, CBD-infused skincare lotions marketed as CaniSkin, and a selection of dermatological remedies for pain and inflammation offered through its CaniDermRX brand. Established in 2018, the company, formerly known as CBD Brands, Inc., maintains its headquarters in Jupiter, Florida.
Prix de l'action
$1.31
Dernière synchronisation: 2023-10-13
Capitalisation boursière
$28.63M
Changement (1 jour)
-9.03%
Changement (1 an)
0.00%
Pays
US
Échange Jupiter Wellness, Inc. (JUPW)

Catégorie

Historique des dividendes pour Jupiter Wellness, Inc. (JUPW)
Jupiter Wellness, Inc. (symbole boursier : JUPW) a versé un total de 0 dividendes.
Le total des dividendes (ajusté en fonction des divisions d’actions) est de : 0.00
Rendement du dividende (TTM) : 0
Versements de dividendes pour Jupiter Wellness, Inc. (JUPW) de 2026 à 2026
Versements annuels de dividendes
Année Dividende (ajusté pour divisions d’actions) Changez
Pas assez de données pour les dates fournies.
Liste de tous les paiements de dividendes
Année Dividende Changez
Pas assez de données pour les dates fournies.
Dividendes versés par des entreprises similaires ou concurrentes